The Community Guide

- gsearch

Search Results

Narrow Results:

2021 1
2018 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

A comparison of transfusion-related adverse reactions among apheresis platelets, whole blood-derived platelets, and platelets subjected to pathogen reduction technology as reported to the National Healthcare Safety Network Hemovigilance Module.

CITE Title : A comparison of transfusion-related adverse reactions among apheresis platelets, whole blood-derived platelets, and platelets subjected to pathogen reduction technology as reported to the National Healthcare Safety Network Hemovigilance Module. Personal Author(s) : Mowla, Sanjida J.;Kracalik, Ian T.;Sapiano, Mathew R. P.;O’Hearn, Lynne;Andrzejewski, Chester;Basavaraju, Sridhar V.; Published Date : April 02 2021;4-2021; Source : Transfus Med Rev. 35(2):78-84 URL : https://stacks.cdc.gov/view/cdc/106851 Mowla, Sanjida J. et al. (2021). A comparison of transfusion-related adverse reactions among apheresis platelets, whole blood-derived platelets, and platelets subjected to pathogen reduction technology as reported to the National Healthcare Safety Network Hemovigilance Module.. 35(2). Mowla, Sanjida J. et al. "A comparison of transfusion-related adverse reactions among apheresis platelets, whole blood-derived platelets, and platelets subjected to pathogen reduction technology as reported to the National Healthcare Safety Network Hemovigilance Module." 35, no. 2 (2021) Mowla, Sanjida J. et al. "A comparison of transfusion-related adverse reactions among apheresis platelets, whole blood-derived platelets, and platelets subjected to pathogen reduction technology as reported to the National Healthcare Safety Network Hemovigilance Module." vol. 35, no. 2, 2021 Export RIS Citation Information.

:

Mowla, Sanjida J. ;

Kracalik, Ian T.

April 02 2021 | Transfus Med Rev. 35(2):78-84

:

Despite advances in transfusion safety, concerns with safety of platelet transfusions remain including platelet-related sepsis and higher reaction rat...
Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States

CITE Title : Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States Personal Author(s) : Edens, Chris;Haass, Kathryn A.;Cumming, Melissa;Osinski, Anthony;O’Hearn, Lynne;Passanisi, Kelly;Eaton, Lynn;Visintainer, Paul;Savinkina, Alexandra;Kuehnert, Matthew J.;Basavaraju, Sridhar V.;Andrzejewski, Chester; Published Date : Nov 14 2018 Source : Transfusion. 59(2):524-533 URL : https://stacks.cdc.gov/view/cdc/75832 Edens, Chris et al. (2018). Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States. 59(2). Edens, Chris et al. "Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States" 59, no. 2 (2018) Edens, Chris et al. "Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States" vol. 59, no. 2, 2018 Export RIS Citation Information.

:

Edens, Chris ;

Haass, Kathryn A.

Nov 14 2018 | Transfusion. 59(2):524-533

:

INTRODUCTION:The National Healthcare Safety Network (NHSN) Hemovigilance Module (HM) collects data on the frequency, severity, and imputability of tra...